Product Description
- Active Ingredient: Trastuzumab (440 mg per vial).
- Mechanism of Action: It is a recombinant immunoglobulin G1 (IgG1) monoclonal antibody. It works by binding specifically to the HER2 receptors on the surface of cancer cells, which blocks the signals that promote cell growth and survival. This action inhibits the growth of cancer cells and can also make them more susceptible to destruction by the body's immune system.
- Uses:
- HER2-positive breast cancer: Used in both early-stage and metastatic (spread to other parts of the body) conditions.
- HER2-positive metastatic gastric (stomach) or gastroesophageal junction adenocarcinoma.
- It can be used alone (monotherapy) or in combination with other chemotherapy agents, depending on the treatment plan prescribed by an oncologist.
- Administration: It is administered as an intravenous (IV) infusion by a healthcare professional in a hospital or clinic setting. The initial infusion is typically given slowly to monitor for any immediate reactions.
- Manufacturer: It is manufactured by Hetero Healthcare Ltd. in India.
- Storage: The injection typically needs to be stored in a refrigerator, between 2 to 8C (36 to 46F), and should not be frozen.
Effective Liver Support and Gallstone ManagementHERTI 440MG offers targeted relief and support for individuals suffering from liver disorders, including primary biliary cirrhosis and certain gallstone conditions. Containing Ursodeoxycholic Acid, this medication helps in dissolving cholesterol-rich gallstones and improving overall liver function when taken as directed by a healthcare professional.
Easy Administration and DosageAs an oral solid capsule, HERTI 440MG is simple to incorporate into daily routines. It is recommended to be taken after meals with water, and capsules should not be crushed or chewed. This straightforward administration ensures consistent therapeutic outcomes and strong patient compliance.
Safety and Supervised UsagePrescribed only under the supervision of qualified healthcare providers, HERTI 440MG ensures safe use, especially during extended therapy. Patients are advised to have periodic liver enzyme checks and to avoid the medicine in cases of hypersensitivity or active inflammatory liver diseases for optimal safety.
FAQ's of HERTI 440MG:
Q: How should I take HERTI 440MG capsules for optimal results?
A: HERTI 440MG should be taken orally after meals with water. It is important not to crush or chew the capsule. Follow your physician's specific instructions regarding the dosage, typically one to two capsules daily.
Q: What are the primary benefits of using HERTI 440MG?
A: HERTI 440MG supports liver health by aiding in the management of cholestatic liver diseases, improving liver function, and assisting in the dissolution of cholesterol-rich gallstones.
Q: When should HERTI 440MG be avoided?
A: This medication should not be used if you have acute inflammatory liver disease or a known hypersensitivity to Ursodeoxycholic Acid. Be sure to inform your doctor about any existing conditions before starting the treatment.
Q: Where should HERTI 440MG be stored at home?
A: Store the capsules in a cool, dry place below 25C, away from direct sunlight and moisture, and keep them out of reach of children.
Q: What precautions should I follow while using HERTI 440MG?
A: Always use HERTI 440MG under medical supervision. For prolonged therapy, regular monitoring of liver enzymes is recommended. Use the medication strictly as prescribed and report any unusual symptoms to your doctor.
Q: Is a prescription necessary to purchase HERTI 440MG?
A: Yes, HERTI 440MG is a prescription-only medicine and should be obtained and used following consultation with a qualified healthcare professional.